Literature DB >> 8670152

Demonstration that 1-trans-epoxysuccinyl-L-leucylamido-(4-guanidino) butane (E-64) is one of the most effective low Mr inhibitors of trypsin-catalysed hydrolysis. Characterization by kinetic analysis and by energy minimization and molecular dynamics simulation of the E-64-beta-trypsin complex.

S K Sreedharan1, C Verma, L S Caves, S M Brocklehurst, S E Gharbia, H N Shah, K Brocklehurst.   

Abstract

1-trans-Epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64) was shown to inhibit beta-trypsin by a reversible competitive mechanism; this contrasts with the widely held view that E-64 is a class-specific inhibitor of the cysteine proteinases and reports in the literature that it does not inhibit a number of other enzymes including, notably, trypsin. The K1, value (3 x 10(-5) M) determined by kinetic analysis of the hydrolysis of N alpha-benzoyl-L-arginine 4-nitroanilide in Tris/HCl buffer, pH 7.4, at 25 degrees C, I = 0.1, catalysed by beta-trypsin is comparable with those for the inhibition of trypsin by benzamidine and 4-aminobenzamidine, which are widely regarded as the most effective low Mr inhibitors of this enzyme. Computer modelling of the beta-trypsin-E64 adsorptive complex, by energy minimization, molecular dynamics simulation and Poisson-Boltzmann electrostatic-potential calculations, was used to define the probable binding mode of E-64; the ligand lies parallel to the active-centre cleft, anchored principally by the dominant electrostatic interaction of the guanidinium cation at one end of the E-64 molecule with the carboxylate anion of Asp-171 (beta-trypsin numbering from Ile-1) in the S1-subsite, and by the interaction of the carboxylate substituent on C-2 of the epoxide ring at the other end of the molecule with Lys-43; the epoxide ring of E-64 is remote from the catalytic site serine hydroxy group. The possibility that E-64 might bind to the cysteine proteinases clostripain (from Clostridium histolyticum) and alpha-gingivain (one of the extracellular enzymes from phyromonas gingivalis) in a manner analogous to that deduced for the beta-trypsin-E-64 complex is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670152      PMCID: PMC1217418          DOI: 10.1042/bj3160777

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Substrate specificity of trypsin investigated by using a genetic selection.

Authors:  L B Evnin; J R Vásquez; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Conformational sampling using high-temperature molecular dynamics.

Authors:  R E Bruccoleri; M Karplus
Journal:  Biopolymers       Date:  1990-12       Impact factor: 2.505

3.  Diffusion-controlled enzymatic reactions.

Authors:  M E Davis; J D Madura; J Sines; B A Luty; S A Allison; J A McCammon
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Five Sepharose-bound ligands for the chromatographic purification of Clostridium collagenase and clostripain.

Authors:  I Emöd; B Keil
Journal:  FEBS Lett       Date:  1977-05-01       Impact factor: 4.124

5.  Isolation and characterization of gingivain, a cysteine proteinase from Porphyromonas gingivalis strain W83.

Authors:  H N Shah; S E Gharbia; D Kowlessur; E Wilkie; K Brocklehurst
Journal:  Biochem Soc Trans       Date:  1990-08       Impact factor: 5.407

Review 6.  Cysteinyl proteinases and their selective inactivation.

Authors:  E Shaw
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1990

7.  Crystal structure of bovine beta-trypsin at 1.5 A resolution in a crystal form with low molecular packing density. Active site geometry, ion pairs and solvent structure.

Authors:  H D Bartunik; L J Summers; H H Bartsch
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

8.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

9.  Molecular dynamics simulation of papain-E-64 (N-[N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl]agmatine) complex.

Authors:  D Yamamoto; H Ohishi; T Ishida; M Inoue; S Sumiya; K Kitamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1990-09       Impact factor: 1.645

10.  Electrical potentials in trypsin isozymes.

Authors:  K Soman; A S Yang; B Honig; R Fletterick
Journal:  Biochemistry       Date:  1989-12-26       Impact factor: 3.162

View more
  7 in total

1.  Giardia duodenalis: protein substrates degradation by trophozoite proteases.

Authors:  Silvana Torossian Coradi; Semíramis Guimarães
Journal:  Parasitol Res       Date:  2006-03-07       Impact factor: 2.289

2.  A human germ line antibody light chain with hydrolytic properties associated with multimerization status.

Authors:  Vikram Sharma; William Heriot; Kirk Trisler; Vaughn Smider
Journal:  J Biol Chem       Date:  2009-10-02       Impact factor: 5.157

3.  Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.

Authors:  Patrick P Ng; Gustavo Helguera; Tracy R Daniels; Simon Z Lomas; Jose A Rodriguez; Gary Schiller; Benjamin Bonavida; Sherie L Morrison; Manuel L Penichet
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

4.  Excretion/secretion products from Schistosoma mansoni adults, eggs and schistosomula have unique peptidase specificity profiles.

Authors:  Jan Dvořák; Pavla Fajtová; Lenka Ulrychová; Adrian Leontovyč; Liliana Rojo-Arreola; Brian M Suzuki; Martin Horn; Michael Mareš; Charles S Craik; Conor R Caffrey; Anthony J O'Donoghue
Journal:  Biochimie       Date:  2015-09-26       Impact factor: 4.079

5.  Enhanced efficacy of bleomycin in bladder cancer cells by photochemical internalization.

Authors:  Yan Baglo; Lars Hagen; Anders Høgset; Finn Drabløs; Marit Otterlei; Odrun A Gederaas
Journal:  Biomed Res Int       Date:  2014-06-30       Impact factor: 3.411

6.  Inhibitors of bacterial protease enzymes for periodontal therapy.

Authors:  Kalid N Hosn; Mary Margaret Jefferson; Carlton Leding; Solomon Shokouh-Amiri; Edwin L Thomas
Journal:  Clin Exp Dent Res       Date:  2015-10-27

7.  Thrombin alters the synthesis and processing of CYR61/CCN1 in human corneal stromal fibroblasts and myofibroblasts through multiple distinct mechanisms.

Authors:  Emily A Andreae; Debra J Warejcka; Sally S Twining
Journal:  Mol Vis       Date:  2020-07-29       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.